These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 34430453)

  • 21. [Indication of Mectizan in human medicine other than onchocerciasis].
    Richard-Lenoble D
    Sante; 1998; 8(1):84-7. PubMed ID: 9592892
    [No Abstract]   [Full Text] [Related]  

  • 22. Ivermectin in human medicine.
    Ottesen EA; Campbell WC
    J Antimicrob Chemother; 1994 Aug; 34(2):195-203. PubMed ID: 7814280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An emerging treatment: Topical ivermectin for papulopustular rosacea.
    Abokwidir M; Fleischer AB
    J Dermatolog Treat; 2015; 26(4):379-80. PubMed ID: 25424053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
    Krotneva SP; Coffeng LE; Noma M; Zouré HG; Bakoné L; Amazigo UV; de Vlas SJ; Stolk WA
    PLoS Negl Trop Dis; 2015; 9(9):e0004051. PubMed ID: 26401658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.
    Kircik LH; Del Rosso JQ; Layton AM; Schauber J
    J Drugs Dermatol; 2016 Mar; 15(3):325-32. PubMed ID: 26954318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ivermectin in scabies.
    del Giudice P
    Curr Opin Infect Dis; 2002 Apr; 15(2):123-6. PubMed ID: 11964911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autochthonous cutaneous larva migrans in Chile. A case report].
    González F CG; Galilea O NM; Pizarro C K
    Rev Chil Pediatr; 2015; 86(6):426-9. PubMed ID: 26455707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based indications for ivermectin in parasitic diseases: An integrated approach to context and challenges in Peru.
    Failoc-Rojas VE; Silva-Díaz H; Maguiña JL; Rodriguez-Morales AJ; Díaz-Velez C; Apolaya-Segura M; Valladares-Garrido MJ
    Parasite Epidemiol Control; 2023 Nov; 23():e00320. PubMed ID: 37731824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
    Jittamala P; Monteiro W; Smit MR; Pedrique B; Specht S; Chaccour CJ; Dard C; Del Giudice P; Khieu V; Maruani A; Failoc-Rojas VE; Sáez-de-Ocariz M; Soriano-Arandes A; Piquero-Casals J; Faisant A; Brenier-Pinchart MP; Wimmersberger D; Coulibaly JT; Keiser J; Boralevi F; Sokana O; Marks M; Engelman D; Romani L; Steer AC; von Seidlein L; White NJ; Harriss E; Stepniewska K; Humphreys GS; Kennon K; Guerin PJ; Kobylinski KC
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009144. PubMed ID: 33730099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Nobel Prize in Medicine 2015 for tropical countries: ivermectin, an antiparasitic drug undeniable against filariasis].
    Danis M; Richard-Lenoble D
    Med Sci (Paris); 2016 Jan; 32(1):110-5. PubMed ID: 26850616
    [No Abstract]   [Full Text] [Related]  

  • 32. Ivermectin: A Review in Rosacea.
    Deeks ED
    Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Larva migrans "saxoniae": larva migrans infection in Saxony].
    Herrmann A; Christoph T; Sebastian G
    J Dtsch Dermatol Ges; 2004 Jan; 2(1):46-8. PubMed ID: 16281881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya.
    Smit MR; Ochomo E; Aljayyoussi G; Kwambai T; Abong'o B; Bayoh N; Gimnig J; Samuels A; Desai M; Phillips-Howard PA; Kariuki S; Wang D; Ward S; Ter Kuile FO
    JMIR Res Protoc; 2016 Nov; 5(4):e213. PubMed ID: 27856406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries.
    Brooks PA; Grace RF
    J Paediatr Child Health; 2002 Aug; 38(4):401-4. PubMed ID: 12174005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages.
    Kobylinski KC; Sylla M; Chapman PL; Sarr MD; Foy BD
    Am J Trop Med Hyg; 2011 Jul; 85(1):3-5. PubMed ID: 21734116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ivermectin systemic availability in adult volunteers treated with different oral pharmaceutical formulations.
    Ceballos L; Alvarez L; Lifschitz A; Lanusse C
    Biomed Pharmacother; 2023 Apr; 160():114391. PubMed ID: 36804122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical ivermectin: a new successful treatment for scabies.
    Victoria J; Trujillo R
    Pediatr Dermatol; 2001; 18(1):63-5. PubMed ID: 11207977
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.